James W. Green - Jun 15, 2022 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role: Chief Executive Officer, Director
Signature: /s/ David Sirois, by power of attorney
Stock symbol: HBIO
Transactions as of: Jun 15, 2022
Transactions value $: $111,300
Form type: 4
Date filed: 6/17/2022, 04:00 PM
Previous filing: Jun 14, 2022
Next filing: Jul 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HBIO	Common Stock	Purchase	$111K	+30K	+1.32%	$3.71	2.3M	Jun 15, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $3.68 to $3.74, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2	Includes (a) the shares described in footenote (1) above, (b) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (c) 109,071 remaining restricted stock units that will vest on June 11, 2023, (d) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (e) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (f) 104,590 remaining restricted stock units that will vest on January 1, 2023, (g) 541,218 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (h) 1,120,797 shares of common stock beneficially owned by the Reporting Person.

Content

This transaction was executed in multiple trades at prices ranging from $3.68 to $3.74, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Includes (a) the shares described in footenote (1) above, (b) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (c) 109,071 remaining restricted stock units that will vest on June 11, 2023, (d) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (e) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (f) 104,590 remaining restricted stock units that will vest on January 1, 2023, (g) 541,218 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (h) 1,120,797 shares of common stock beneficially owned by the Reporting Person.